Immunofluorescence(IF) evaluation of liver tumor samples from this in vivo experiment also showed a significant increase in tumor-infiltratingCD4+ and CD8+ T cells in the anti-PD-1 antibodymonotherapy group and in the STR-V-53 plus anti-PD-1antibody group (Figure 6e–h). Here, PDCD1 is linked to neoplasm.